InMode Ltd. boasts superior fundamentals, yet trades at undervalued market multiples due to its unique risk profile. The company is a leader in the global aesthetics market with proprietary RF-based ...

YOKNEAM, Israel, Nov. 5, 2025/ PRNewswire/-- InMode Ltd., a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended ...

InMode Ltd INMD reported Q2 sales of $136.1 million, an increase of 20% Y/Y, beating the consensus of $132 million and slightly above the preliminary numbers. Adjusted EPS reached $0.72, compared to ...

On March 13, 2026, InMode Ltd. announced that its Board of Directors approved a share repurchase program for up to 6,380,000 shares, or 10% of its outstanding stock, to be funded with existing cash.

InMode (NASDAQ:INMD) is gearing up to announce its quarterly earnings on Tuesday, 2026-02-10. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

InMode's CFO says a multi-year demand downturn is beginning to stabilize and management is targeting 2026 revenue to be "flat", while noting patient demand is the primary headwind and higher interest ...

A lot of (digital) ink tends to get spilled about how much businesses grow their revenues each quarter. But sometimes, like with InMode's (NASDAQ: INMD) second-quarter earnings, the most exciting ...

We are writing to make you aware that we have expressed interest to InMode’s leadership in pursuing an acquisition by Steel Partners of 51% of the Company’s outstanding shares for $18.00 per share, ...

On Wednesday, 11 March 2026, InMode Ltd (NASDAQ:INMD) presented its strategic vision at the Barclays 28th Annual Global Healthcare Conference. The company, navigating a challenging market environment, ...